My Application Form Status

Check the status of your application form with Angel Broking.
Arq - The Hyper Intelligent Investment Engine By Angel Broking
Thirani Projects appoints director
Jan 30,2017

Thirani Projects announced that the Board have appointed Sudarson Kayori as Additional Independent Director to hold office as such w.e.f. 30 January 2017 till the conclusion of ensuing Annual General Meeting.

Powered by Capital Market - Live News

Adani Power allots 3,90,43,268 equity shares
Jan 30,2017

Adani Power announced that the convertible warrant holders, to whom the warrants were allotted in the month of May, 2016 on preferential basis, have exercised their rights for conversion and applied for conversion of part of the warrants into equity shares. Consequently, Management Committee of the Board of Directors of the Company at its meeting held on 30 January 2017 has made allotment of total 3,90,43,268 Equity Shares of the face value of Rs. 10/- each (with a premium of Rs. 22.54 per equity share) to the said convertible warrant holders.

Powered by Capital Market - Live News

Tata Chemicals signs MoU with Government of Andhra Pradesh
Jan 30,2017

Tata Chemicals has signed an MOU with the Government of Andhra Pradesh on 28 January 2017 during the 2nd Sunrise Andhra Pradesh Investment Meet for creation and development of Biotechnology based nutritional products such as Oligosaccharides and other nutritional products in Nellore district involving an investments of approximately Rs. 200 - 250 crore.

Powered by Capital Market - Live News

Rushil Decor signs MoU with Government of Andhra Pradesh
Jan 30,2017

Rushil Decor has executed a Memorandum of Understanding (MOU) on 28 January 2017 with Government of Andhra Pradesh during 2nd Sunrise Andhra Pradesh Investment Meet & 23rd edition of CII Partnership Summit.

As per MOU, the Company agreed for establishment of Thin & Thick MDF Board and other Panel Board Manufacturing Facility at Atchutapuram Dist. Vishakhapatnam.

Powered by Capital Market - Live News

Idea Cellular plans to raise Rs 500 crore
Jan 30,2017

Idea Cellular is proposing to issue unsecured redeemable non-convertible debentures amounting to Rs 500 crore on private placement basis.

Powered by Capital Market - Live News

Everest Industries announces resignation of director
Jan 30,2017

Everest Industries announced that Madan Lal Narula has tendered his resignation from the directorship of the Company w.e.f. 30 January 2017 as his tenure as Independent Director as per the Companys policy ended on 29 January 2017.

Powered by Capital Market - Live News

Board of Vertex Securities approves allotment of equity shares under ESOP
Jan 30,2017

Vertex Securities announced that the Board of Directors of the Company at its meeting held on 28 January 2017, have approved the allotment of 2,58,439 Equity shares of Rs. 2 each under ESOP Scheme.

Powered by Capital Market - Live News

Monsanto India appoints company secretary and compliance officer
Jan 30,2017

Monsanto India announced that the Board of Directors at their meeting held on 30 January 2017 have approved the appointment of Monika Gupta as the Company Secretary & Compliance Officer of the Company with effect from 30 January 2017.

Powered by Capital Market - Live News

Tech Mahindra announces change in company secretary and compliance officer
Jan 30,2017

Tech Mahindra announced that Jayararnan G. Company Secretary and Chief Compliance Officer of the Company will retire at the close of business hours on 31 March 2017.

Further, Anil Khatri has been appointed as a Company Secretary and Compliance Officer of the Company with effect from01 April 2017.

Powered by Capital Market - Live News

PNB Housing Finance to raise Rs 1025 crore
Jan 30,2017

PNB Housing Finance announced private placement of Secured Redeemable Non-Convertible Bonds (NCD) for a total amount of Rs 1,025 crore including green shoe option. The issue will open on 30 January 2017 and close on 31 January 2017.

The Companys NCD Issue is rated as AAA by Care and Ind AAA by India Ratings and is issued at a semi-annual fixed coupon rate of 7.46% for a tenure of 3 year and 3 months.

The proceeds from the issue will be utilised by the Bank for expansion of branch network in Tier 2 and Tier 3 cities and grow its Loan book while maintaining an adequate capital adequacy ratio.

Powered by Capital Market - Live News

Sundaram Finance to consider declaration of interim dividend for FY 2017
Jan 30,2017

Sundaram Finance announced that a meeting of the Board of Directors of the Company has been convened on 17 February 2017, inter alia, to consider the following:

1. declaration of Interim dividend for the financial year 2016-17 and fixing Record Date for the same;

2. approval of postal ballot notice to the shareholders in connection with the intention to raise funds by making offer(s) or invitation(s) to subscribe to listed non-convertible debentures on private placement basis, in accordance with the provisions of S.42 read with S.71 of the Companies Act. 2013.

Powered by Capital Market - Live News

Punjab & Sind Bank announces cessation of director
Jan 30,2017

Punjab & Sind Bank announced that Anita Karnavar Part-Time Non-Official Director on the Board ot Directors of Punjab & Sind Bank appointed by Government of India as per Notification dated 30 January 2014, has ceased to be Director of the Bank on completion of her tenure on 29 January 2017.

Powered by Capital Market - Live News

Piramal Enterprises acquires portfolio of intrathecal spasticity and pain management drugs from Mallinckrodt
Jan 30,2017

Piramal Enterprises announced that its wholly owned Critical Care subsidiary in the UK has entered into an agreement to acquire aportfolio of intrathecal spasticity and pain management drugs from Mallinckrodt LLC (Mallinckrodt) in an all cash deal for a consideration of US$ 171 million and up to an additional US$ 32 million payabledepending on financial performance of the acquired assets over the next 3 years.

The portfolio acquired includes Gablofenn++ (baclofen), a severe spasticity management product, which is currently marketed in the United States, and two pain management products, which are currently underdevelopment. Gablofenn++ has also been approved for launch in 8 European markets. Gablofenn++ is the only intrathecal baclofen drug available in vials and pre-filled syringes, which are preferred by users over the competing products available in ampoules. The pain management drugs under development are also for intrathecal administration. In the twelve months ending 30 September 2016, the acquired portfolio generated revenues of US$ 44.6 million.

Powered by Capital Market - Live News

Mideast (India) appoints company secretary and compliance officer
Jan 30,2017

Mideast (India) announced Preeti S Nair has been appointed as Company Secretary and Compliance Officer of the Company w.e.f. 18 January 2017 pursuant to Section 203 of the Companies Act, 2013 and Regulation 6(1) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Powered by Capital Market - Live News

Accelya Kale Solutions to consider December quarter results and interim dividend
Jan 30,2017

Accelya Kale Solutions announced that the meeting of the Board of Directors will be held on 07 February 2017, inter alia, to consider the following;

1. Unaudited financial results for the quarter and six months ended 31 December 2016;

2. Declaration of interim dividend, if any.

Powered by Capital Market - Live News